The interaction between hippocampal cholinergic and nitrergic neurotransmission coordinates NMDA-dependent behavior and autonomic changes induced by contextual fear retrieval

Psychopharmacology (Berl). 2022 Oct;239(10):3297-3311. doi: 10.1007/s00213-022-06213-6. Epub 2022 Aug 18.

Abstract

Rationale: Re-exposing an animal to an environment previously paired with an aversive stimulus evokes large alterations in behavioral and cardiovascular parameters. Dorsal hippocampus (dHC) receives important cholinergic inputs from the basal forebrain, and respective acetylcholine (ACh) levels are described to influence defensive behavior. Activation of muscarinic M1 and M3 receptors facilitates autonomic and behavioral responses along threats. Evidence show activation of cholinergic receptors promoting formation of nitric oxide (NO) and cyclic guanosine monophosphate (cGMP) in dHC. Altogether, the action of ACh and NO on conditioned responses appears to converge within dHC.

Objectives: As answer about how ACh and NO interact to modulate defensive responses has so far been barely addressed, we aimed to shed additional light on this topic.

Methods: Male Wistar rats had guide cannula implanted into the dHC before being submitted to the contextual fear conditioning (3footshocks/085 mA/2 s). A catheter was implanted in the femoral artery the next day for cardiovascular recordings. Drugs were delivered into dHC 10 min before contextual re-exposure, which occurred 48 h after the conditioning procedure.

Results: Neostigmine (Neo) amplified the retrieval of conditioned responses. Neo effects (1 nmol) were prevented by the prior infusion of a M1-M3 antagonist (fumarate), a neuronal nitric oxide synthase inhibitor (NPLA), a NO scavenger (cPTIO), a guanylyl cyclase inhibitor (ODQ), and a NMDA antagonist (AP-7). Pretreatment with a selective M1 antagonist (pirenzepine) only prevented the increase in autonomic responses induced by Neo.

Conclusion: The results show that modulation in the retrieval of contextual fear responses involves coordination of the dHC M1-M3/NO/cGMP/NMDA pathway.

Keywords: Acetylcholine; Contextual fear conditioning; Dorsal hippocampus; NMDA receptors; Nitric oxide.

MeSH terms

  • Acetylcholine
  • Animals
  • Cholinergic Agents / pharmacology
  • Fear / physiology
  • Fumarates / pharmacology
  • Guanosine Monophosphate / pharmacology
  • Guanylate Cyclase / metabolism
  • Guanylate Cyclase / pharmacology
  • Hippocampus
  • Male
  • N-Methylaspartate* / pharmacology
  • Neostigmine / pharmacology
  • Nitric Oxide Synthase Type I / metabolism
  • Nitric Oxide* / metabolism
  • Pirenzepine / pharmacology
  • Rats
  • Rats, Wistar
  • Receptors, Cholinergic / metabolism
  • Receptors, N-Methyl-D-Aspartate
  • Synaptic Transmission

Substances

  • Cholinergic Agents
  • Fumarates
  • Receptors, Cholinergic
  • Receptors, N-Methyl-D-Aspartate
  • Nitric Oxide
  • Neostigmine
  • Pirenzepine
  • N-Methylaspartate
  • Guanosine Monophosphate
  • Nitric Oxide Synthase Type I
  • Guanylate Cyclase
  • Acetylcholine

Grants and funding